Latest Insider Transactions at Boston Scientific Corp (BSX)
This section provides a real-time view of insider transactions for Boston Scientific Corp (BSX). The data is sourced from Form 4 filings with the SEC, which are filed by insiders of BOSTON SCIENTIFIC CORP to disclose their transactions in the company's securities. By reviewing this information, investors can gain insights into the trading activity of BOSTON SCIENTIFIC CORP's insiders and make more informed investment decisions.
Insider Transaction List
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Feb 06
2024
|
Eric Francis Yves Thepaut EVP & Pres, Eur, Mid-East, Afr |
SELL
Payment of exercise price or tax liability
|
Direct |
11,579
-30.65%
|
-
|
|
Feb 06
2024
|
Eric Francis Yves Thepaut EVP & Pres, Eur, Mid-East, Afr |
BUY
Grant, award, or other acquisition
|
Direct |
20,000
+34.62%
|
-
|
|
Feb 06
2024
|
Michael F Mahoney Chairman, President & CEO |
SELL
Payment of exercise price or tax liability
|
Direct |
65,047
-3.82%
|
-
|
|
Feb 06
2024
|
Michael F Mahoney Chairman, President & CEO |
BUY
Grant, award, or other acquisition
|
Direct |
146,666
+7.94%
|
-
|
|
Feb 06
2024
|
Jeffrey B. Mirviss EVP&Pres, Periph Intervent |
SELL
Payment of exercise price or tax liability
|
Direct |
12,160
-14.61%
|
-
|
|
Feb 06
2024
|
Jeffrey B. Mirviss EVP&Pres, Periph Intervent |
BUY
Grant, award, or other acquisition
|
Direct |
26,666
+24.26%
|
-
|
|
Feb 06
2024
|
John Bradley Sorenson EVP, Global Operations |
SELL
Payment of exercise price or tax liability
|
Direct |
5,472
-10.36%
|
-
|
|
Feb 06
2024
|
John Bradley Sorenson EVP, Global Operations |
BUY
Grant, award, or other acquisition
|
Direct |
12,000
+18.52%
|
-
|
|
Jan 12
2024
|
Joseph Michael Fitzgerald EVP & Group Pres, Cardiology |
SELL
Open market or private sale
|
Direct |
11,660
-6.3%
|
$699,600
$60.0 P/Share
|
|
Jan 09
2024
|
Jeffrey B. Mirviss EVP&Pres, Periph Intervent |
SELL
Open market or private sale
|
Direct |
15,172
-21.14%
|
$895,148
$59.25 P/Share
|
|
Jan 09
2024
|
Jeffrey B. Mirviss EVP&Pres, Periph Intervent |
BUY
Exercise of conversion of derivative security
|
Direct |
15,172
+17.45%
|
$242,752
$16.31 P/Share
|
|
Jan 04
2024
|
Jeffrey B. Mirviss EVP&Pres, Periph Intervent |
SELL
Open market or private sale
|
Direct |
15,000
-20.95%
|
$870,000
$58.4 P/Share
|
|
Jan 04
2024
|
Jeffrey B. Mirviss EVP&Pres, Periph Intervent |
BUY
Exercise of conversion of derivative security
|
Direct |
15,000
+17.32%
|
$240,000
$16.31 P/Share
|
|
Jan 03
2024
|
Jeffrey B. Mirviss EVP&Pres, Periph Intervent |
SELL
Open market or private sale
|
Direct |
11,931
-17.41%
|
$680,067
$57.82 P/Share
|
|
Jan 01
2024
|
Daniel J. Brennan EVP and CFO |
SELL
Payment of exercise price or tax liability
|
Direct |
8,199
-3.28%
|
$467,343
$57.81 P/Share
|
|
Jan 01
2024
|
Daniel J. Brennan EVP and CFO |
BUY
Exercise of conversion of derivative security
|
Direct |
23,979
+8.75%
|
-
|
|
Jan 01
2024
|
Arthur C Butcher EVP& Grp Pres, MedSurg & APAC |
SELL
Payment of exercise price or tax liability
|
Direct |
6,733
-30.89%
|
$383,781
$57.81 P/Share
|
|
Jan 01
2024
|
Arthur C Butcher EVP& Grp Pres, MedSurg & APAC |
BUY
Exercise of conversion of derivative security
|
Direct |
14,823
+40.47%
|
-
|
|
Jan 01
2024
|
Wendy Carruthers EVP, Human Resources |
SELL
Payment of exercise price or tax liability
|
Direct |
5,380
-10.14%
|
$306,660
$57.81 P/Share
|
|
Jan 01
2024
|
Wendy Carruthers EVP, Human Resources |
BUY
Exercise of conversion of derivative security
|
Direct |
11,772
+18.16%
|
-
|
|
Jan 01
2024
|
Joseph Michael Fitzgerald EVP & Group Pres, Cardiology |
SELL
Payment of exercise price or tax liability
|
Direct |
10,908
-5.56%
|
$621,756
$57.81 P/Share
|
|
Jan 01
2024
|
Joseph Michael Fitzgerald EVP & Group Pres, Cardiology |
BUY
Exercise of conversion of derivative security
|
Direct |
21,799
+10.01%
|
-
|
|
Jan 01
2024
|
Michael F Mahoney Chairman, President & CEO |
SELL
Payment of exercise price or tax liability
|
Direct |
40,104
-2.51%
|
$2,285,928
$57.81 P/Share
|
|
Jan 01
2024
|
Michael F Mahoney Chairman, President & CEO |
BUY
Exercise of conversion of derivative security
|
Direct |
95,919
+5.67%
|
-
|
|
Jan 01
2024
|
Jeffrey B. Mirviss EVP&Pres, Periph Intervent |
SELL
Payment of exercise price or tax liability
|
Direct |
5,508
-7.44%
|
$313,956
$57.81 P/Share
|
|
Jan 01
2024
|
Jeffrey B. Mirviss EVP&Pres, Periph Intervent |
BUY
Exercise of conversion of derivative security
|
Direct |
17,439
+19.07%
|
-
|
|
Jan 01
2024
|
John Bradley Sorenson EVP, Global Operations |
SELL
Payment of exercise price or tax liability
|
Direct |
3,729
-8.37%
|
$212,553
$57.81 P/Share
|
|
Jan 01
2024
|
John Bradley Sorenson EVP, Global Operations |
BUY
Exercise of conversion of derivative security
|
Direct |
7,848
+14.98%
|
-
|
|
Jan 01
2024
|
Eric Francis Yves Thepaut EVP & Pres, Eur, Mid-East, Afr |
SELL
Payment of exercise price or tax liability
|
Direct |
7,573
-29.88%
|
$431,661
$57.81 P/Share
|
|
Jan 01
2024
|
Eric Francis Yves Thepaut EVP & Pres, Eur, Mid-East, Afr |
BUY
Exercise of conversion of derivative security
|
Direct |
13,080
+34.04%
|
-
|
|
Dec 29
2023
|
Joseph Michael Fitzgerald EVP & Group Pres, Cardiology |
SELL
Open market or private sale
|
Direct |
81,940
-31.99%
|
$4,670,580
$57.5 P/Share
|
|
Dec 29
2023
|
Joseph Michael Fitzgerald EVP & Group Pres, Cardiology |
BUY
Exercise of conversion of derivative security
|
Direct |
58,189
+18.51%
|
$931,024
$16.31 P/Share
|
|
Dec 15
2023
|
Wendy Carruthers EVP, Human Resources |
SELL
Open market or private sale
|
Direct |
11,672
-22.05%
|
$641,960
$55.61 P/Share
|
|
Dec 15
2023
|
Wendy Carruthers EVP, Human Resources |
BUY
Exercise of conversion of derivative security
|
Direct |
6,409
+5.88%
|
$89,726
$14.7 P/Share
|
|
Dec 06
2023
|
Jeffrey B. Mirviss EVP&Pres, Periph Intervent |
SELL
Open market or private sale
|
Direct |
353
-0.62%
|
$19,415
$55.03 P/Share
|
|
Dec 03
2023
|
Jeffrey B. Mirviss EVP&Pres, Periph Intervent |
SELL
Payment of exercise price or tax liability
|
Direct |
296
-0.52%
|
$16,576
$56.14 P/Share
|
|
Dec 03
2023
|
Jeffrey B. Mirviss EVP&Pres, Periph Intervent |
BUY
Exercise of conversion of derivative security
|
Direct |
649
+1.12%
|
-
|
|
Nov 20
2023
|
Arthur C Butcher EVP& Grp Pres, MedSurg & APAC |
SELL
Open market or private sale
|
Direct |
8,278
-54.26%
|
$447,012
$54.06 P/Share
|
|
Nov 20
2023
|
Arthur C Butcher EVP& Grp Pres, MedSurg & APAC |
BUY
Exercise of conversion of derivative security
|
Direct |
3,859
+20.19%
|
$65,603
$17.26 P/Share
|
|
Nov 15
2023
|
Wendy Carruthers EVP, Human Resources |
SELL
Open market or private sale
|
Direct |
11,671
-20.05%
|
$630,234
$54.17 P/Share
|
|
Nov 15
2023
|
Wendy Carruthers EVP, Human Resources |
BUY
Exercise of conversion of derivative security
|
Direct |
6,408
+5.36%
|
$89,712
$14.7 P/Share
|
|
Nov 08
2023
|
Jeffrey B. Mirviss EVP&Pres, Periph Intervent |
SELL
Bona fide gift
|
Direct |
4,000
-6.6%
|
-
|
|
Nov 06
2023
|
Michael F Mahoney Chairman, President & CEO |
SELL
Open market or private sale
|
Direct |
113,356
-7.03%
|
$5,894,512
$52.51 P/Share
|
|
Nov 06
2023
|
Michael F Mahoney Chairman, President & CEO |
BUY
Exercise of conversion of derivative security
|
Direct |
113,356
+3.46%
|
$1,586,984
$14.7 P/Share
|
|
Oct 16
2023
|
Wendy Carruthers EVP, Human Resources |
SELL
Open market or private sale
|
Direct |
11,671
-18.39%
|
$571,879
$49.79 P/Share
|
|
Oct 16
2023
|
Wendy Carruthers EVP, Human Resources |
BUY
Exercise of conversion of derivative security
|
Direct |
6,408
+4.92%
|
$89,712
$14.7 P/Share
|
|
Oct 09
2023
|
Michael F Mahoney Chairman, President & CEO |
SELL
Open market or private sale
|
Direct |
113,355
-7.03%
|
$5,894,460
$52.09 P/Share
|
|
Oct 09
2023
|
Michael F Mahoney Chairman, President & CEO |
BUY
Exercise of conversion of derivative security
|
Direct |
113,355
+3.46%
|
$1,586,970
$14.7 P/Share
|
|
Sep 20
2023
|
Joseph Michael Fitzgerald EVP & Group Pres, Cardiology |
SELL
Open market or private sale
|
Direct |
15,867
-7.42%
|
$872,685
$55.0 P/Share
|
|
Sep 15
2023
|
Wendy Carruthers EVP, Human Resources |
SELL
Open market or private sale
|
Direct |
11,671
-16.98%
|
$618,563
$53.95 P/Share
|